AT269350B - Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen - Google Patents

Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen

Info

Publication number
AT269350B
AT269350B AT1097465A AT1097465A AT269350B AT 269350 B AT269350 B AT 269350B AT 1097465 A AT1097465 A AT 1097465A AT 1097465 A AT1097465 A AT 1097465A AT 269350 B AT269350 B AT 269350B
Authority
AT
Austria
Prior art keywords
new
production
antibiotic substances
antibiotic
substances
Prior art date
Application number
AT1097465A
Other languages
English (en)
Original Assignee
Danbal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbal Ag filed Critical Danbal Ag
Application granted granted Critical
Publication of AT269350B publication Critical patent/AT269350B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1097465A 1964-12-07 1965-12-06 Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen AT269350B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US416599A US3361742A (en) 1964-12-07 1964-12-07 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides

Publications (1)

Publication Number Publication Date
AT269350B true AT269350B (de) 1969-03-10

Family

ID=23650586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1097465A AT269350B (de) 1964-12-07 1965-12-06 Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen

Country Status (11)

Country Link
US (1) US3361742A (de)
AT (1) AT269350B (de)
BE (1) BE673376A (de)
BR (1) BR6575537D0 (de)
CH (1) CH475997A (de)
DE (1) DE1467872A1 (de)
ES (1) ES320436A1 (de)
FR (1) FR1553664A (de)
GB (1) GB1092888A (de)
NL (1) NL6515880A (de)
SE (1) SE316136B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523941A (en) * 1967-03-06 1970-08-11 Hoffmann La Roche Benzodiazepine compounds and process for their preparation
US3524849A (en) * 1967-10-27 1970-08-18 Hoffmann La Roche Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein
FR2027356A1 (en) * 1968-12-30 1970-09-25 Fujisawa Pharmaceutical Co Benzodiazepinone antibiotics
JPS5279082A (en) * 1975-12-25 1977-07-02 Green Cross Corp:The Preparation of anti-tumor compound
JPS585916B2 (ja) 1977-12-27 1983-02-02 株式会社ミドリ十字 新規ベンゾジアゼピン系化合物
CA1214774A (en) * 1983-02-10 1986-12-02 Yusei Shiraga Benzodiazepine derivative
AUPO470197A0 (en) * 1997-01-21 1997-02-13 Attfield, Paul Victor Fluorescent dyes from microorganisms
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
NZ602932A (en) 2010-04-15 2014-08-29 Seattle Genetics Inc Targeted pyrrolobenzodiazapine conjugates
MX341524B (es) 2011-09-20 2016-08-24 Medimmune Ltd Pirrolobenzodiazepinas como compuestos pbd dimericos asimetricos para inclusion en conjugados dirigidos.
EP2751110B1 (de) 2011-10-14 2017-04-19 MedImmune Limited Asymmetrische Bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-on) Derivate zur Behandlung von proliferativen oder Autoimmunerkrankungen
KR101891859B1 (ko) 2011-10-14 2018-08-24 메디뮨 리미티드 피롤로벤조디아제핀
AU2012322613B2 (en) 2011-10-14 2016-04-21 Medimmune Limited Pyrrolobenzodiazepines and targeted conjugates
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
SI2906253T1 (sl) 2012-10-12 2018-11-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin-protitelo proti PSMA
SMT201800346T1 (it) 2012-10-12 2018-09-13 Medimmune Ltd Coniugati pirrolobenzodiazepina-anticorpo
WO2014057122A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
US10695433B2 (en) 2012-10-12 2020-06-30 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
EP2906250B1 (de) 2012-10-12 2018-05-30 ADC Therapeutics SA Pyrrolobenzodiazepin-anti-psma-antikörperkonjugate
PT2906298T (pt) 2012-10-12 2018-12-28 Medimmune Ltd Conjugados de pirrolobenzodiazepina-anticorpos
WO2014057074A1 (en) 2012-10-12 2014-04-17 Spirogen Sàrl Pyrrolobenzodiazepines and conjugates thereof
ES2713164T3 (es) 2012-10-12 2019-05-20 Medimmune Ltd Pirrolobenzodiazepinas y conjugados de las mismas
EP2906249B1 (de) 2012-10-12 2018-06-27 MedImmune Limited Synthese und zwischenprodukte pyrrolobenzodiazepinderivaten zur konjugation
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054985B1 (de) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
US10780096B2 (en) 2014-11-25 2020-09-22 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
ES2871001T3 (es) 2017-02-08 2021-10-28 Adc Therapeutics Sa Conjugados de pirrolobenzodiazepinas y anticuerpos
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
WO2018192944A1 (en) 2017-04-18 2018-10-25 Medimmune Limited Pyrrolobenzodiazepine conjugates
CA3057748A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
ES2988683T3 (es) 2017-06-14 2024-11-21 Adc Therapeutics Sa Pautas posológicas para la administración de un CAF anti-CD19
SG11202000358YA (en) 2017-08-18 2020-02-27 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
MX2021010477A (es) 2019-03-15 2021-10-01 Medimmune Ltd Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247187A (en) * 1963-07-10 1966-04-19 Hoffmann La Roche Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones

Also Published As

Publication number Publication date
FR1553664A (de) 1969-01-17
CH475997A (de) 1969-07-31
BR6575537D0 (pt) 1973-09-06
DE1467872A1 (de) 1969-05-14
ES320436A1 (es) 1966-05-16
NL6515880A (de) 1966-06-08
BE673376A (de) 1966-04-01
US3361742A (en) 1968-01-02
GB1092888A (en) 1967-11-29
SE316136B (de) 1969-10-20

Similar Documents

Publication Publication Date Title
AT269350B (de) Verfahren zur Herstellung von neuen, antibiotisch wirksamen Substanzen
CH478156A (de) Verfahren zur Herstellung neuartiger Antibiotika
CH456636A (de) Verfahren zur Herstellung von neuen Aminen
CH475241A (de) Verfahren zur Herstellung von neuen Pyrrolderivaten
AT264136B (de) Verfahren zur Herstellung von neuen Copolyestern
CH473117A (de) Verfahren zur Herstellung von neuen Verbindungen
CH468977A (de) Verfahren zur Herstellung von neuen Carbamaten
CH471129A (de) Verfahren zur Herstellung von neuen Noralkaloiden
CH488640A (de) Verfahren zur Herstellung von neuen Cycloheptadienen
AT250981B (de) Verfahren zur Herstellung von neuen alkalilöslichen Kondensationsprodukten
AT265515B (de) Verfahren zur Herstellung von neuen Penicillinen
AT266314B (de) Verfahren zur Herstellung des neuen Antibiotikums Lincomycin B
AT254203B (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT261804B (de) Verfahren zur Herstellung von neuen wasserlöslichen, antibiotisch wirksamen Verbindungen
AT264711B (de) Verfahren zur Herstellung von neuen Penicillinen
AT264003B (de) Verfahren zur Herstellung von neuen Penicillinen
AT284089B (de) Verfahren zur herstellung von neuen substituierten beta-phenylaethanolen
CH457433A (de) Verfahren zur Herstellung von neuen basisch substituierten Pseudoindolen
AT282079B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
AT255435B (de) Verfahren zur Herstellung von neuen organischen Zinn-Bor-Verbindungen
CH434265A (de) Verfahren zur Herstellung von neuen Azepinderivaten
AT257627B (de) Verfahren zur Herstellung von neuen S-Amino-iso-thio-harnstoffen
AT268552B (de) Verfahren zur Herstellung von neuen α-Alkyl-thyroninen
CH486421A (de) Verfahren zur Herstellung von neuen Phenoxyaminopropanen
AT270867B (de) Verfahren zur Herstellung von neuen Penicillinen